Skip to content

Aurobindo Pharma hits 52-week high on US FDA clean chit to Telangana unit

Broking house Sharekhan in its November 13 report has has upgraded the stock to buy with a revised price target of Rs 1,163.

Read More

​ Broking house Sharekhan in its November 13 report has has upgraded the stock to buy with a revised price target of Rs 1,163. Broking house Sharekhan in its November 13 report has has upgraded the stock to buy with a revised price target of Rs 1,163.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish